Ubix Therapeutics

About:

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

Top Investors: Mirae Asset Venture Investment, Atinum Partners, Korea Development Bank, Partners Investment, UTC Investment Co.

Description:

Total Funding Amount:

19B KRW

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2018-01-01

Contact Email:

info(AT)ubixtrx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-01-01

IPO Status:

Private

Industries: